Europe Establishes Its First Clinical Guide for Photobiomodulation in Cancer Care
Dr. Joseph Mercola - Take Control of Your Health
Briana Mercola
4.6 • 1.6K Ratings
🗓️ 14 February 2026
⏱️ 8 minutes
🧾️ Download transcript
Summary
- Photobiomodulation (PBM) is a light-based therapy that uses specific wavelengths to interact with body tissues, influencing cellular activity without heat and supporting recovery across both medical and general wellness settings
- Europe recently released its first formal clinical guide for PBM in oncology, marking a shift toward standardized use of light-based supportive care across cancer treatment centers
- Clinical research shows PBM is most strongly supported for managing oral mucositis and radiation-related skin damage, two common cancer complications that can interfere with eating, speaking, and treatment continuity
- Beyond cancer care, PBM has been studied for wound healing, nerve pain, musculoskeletal recovery, skin health, and hair loss, with consensus reviews supporting its safety when properly applied
- Effective PBM depends on correct wavelength selection, dosing, and device quality, with red and near-infrared light delivering biologically active energy when used within established therapeutic ranges
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Have the burns, sores, or nerve pain from cancer treatment ever made you wonder if light |
| 0:05.1 | itself could help you keep eating, speaking, and healing without adding more strength? |
| 0:10.3 | Welcome to Dr. Mercola's cellular wisdom. Stay informed with quick, easy-to-listen |
| 0:15.0 | summaries of our latest articles, perfect for when you're on the go. No reading required. |
| 0:19.6 | Subscribe for free at Mercola.com for the latest health insights. |
| 0:23.5 | Hello and welcome to Dr. Mercola's cellular wisdom. I'm Ethan Foster. |
| 0:29.1 | And today we're examining photobiomodulation, P, BM, light at specific wavelengths used to influence cellular activity without heat. |
| 0:39.1 | Now moving into standardized use across European cancer centers. |
| 0:43.2 | I'm Alara Sky, and we're focusing on what this new clinical framework means for you, |
| 0:48.0 | how PBM interacts with your cells, and the practical dosing and device choices laid out, |
| 0:53.6 | so you can evaluate whether this therapy fits your situation. |
| 0:58.0 | Europe just published its first formal clinical guide for PBM in oncology |
| 1:02.7 | through the French-speaking Association for Supportive Care and Cancer, |
| 1:07.0 | led by Dr. Antoine LaMere. |
| 1:09.3 | It sets out when and how PBM should be used, so you receive |
| 1:13.2 | consistent supportive care no matter the clinic. The strongest evidence targets two problems |
| 1:18.6 | that derail treatment continuity, oral mucocitis and radiation-related skin damage. If mouth pain |
| 1:26.0 | stops you from eating or speaking, or if irradiated skin breaks down, |
| 1:30.5 | PBM is supported as a way to reduce severity and duration so you can stay on schedule. |
| 1:35.7 | The guide also lists conditions where evidence is moderate but promising, swelling after lymphatic |
| 1:40.9 | damage, dry mouth from head and neck radiation, restricted jaw movement, |
| 1:46.0 | bone injury from impaired blood flow after radiation, difficulty swallowing, voice changes, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Briana Mercola, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Briana Mercola and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.